A Gabriel Rodriguez page used as a vehicle to reach investor community in connection with companies I
08/07/2023
Enter an extraordinary journey into the realm of STEM CELLS – the unsung heroes of your well-being! 🌱🌍 Discover how these tiny powerhouses hold the key to rejuvenating tissues, healing injuries, and even turning back the clock on aging! From boosting your immune system to envisioning a world where diseases are conquered through regenerative magic, join us in celebrating the incredible potential of stem cells. 🎉 Let's spread the word, ignite a global movement, and make wellness a priority for all. Don't miss out – like, share, and follow for an inside look at the fascinating world of stem cells and their magical role in shaping a healthier, happier you! 🌟🔬
Hear Dr. Allan Somersall talk about the revolution in nutritional supplementation.
07/22/2023
Get to know your body! Stem Cell Nutrition is for you.
At 35 years – stem cell release rate drops by approximately 45%
At 50 years – stem cell release rate drops by approximately 50%
At 65 years – stem cell release rate drops by approximately 90% This is when we need them the most to fight disease, sickness, and, well GETTING OLD”!
Ticker {STEK) https://fasttrader.stemtech.com/
Unlocking the Power Within: Unveiling the Revolutionary Potential of Stem Cell Nutrition June 22, 2023 A+ A- Email Print Introduction: In recent years, the field of stem cell nutrition has captivated researchers, healthcare professionals, and the general public with its potential to revolutionize he...
03/23/2023
Stemtech right smack in middle of Growth
Stock Slammed to current levels(.11) from $11,50
$STEK
The Stem Cell Manufacturing market is a rapidly growing industry that is expected to see enormous growth in the coming years. The report by TMR provides comprehensive insights into the various factors influencing the market dynamics. It uses a variety of analytical tools and research methodologies to identify market trends and analyze consumer behaviors.
Stemtech, a company at the forefront of stem cell research and development, is positioned right in the middle of this growth trend. However, its current stock price of just .11 cents is a far cry from its former glory, when it was valued at $11.50 per share. Despite this setback, Stemtech remains committed to advancing the field of stem cell therapy and exploring the potential of stem cells in treating a wide range of diseases and medical conditions. With its innovative products and cutting-edge research, Stemtech is poised to become a major player in the stem cell manufacturing market and drive significant growth in the coming years.
$FRC $BTC $META $AAPL $COIN $TSLA
The global market is estimated to attain a valuation of US 26 6 billion by the end of 2033 states a study by Transparency Market Research TMR Besides the report notes that the market is prognosticated to expand at a ...
Take a few minutes and check out Stemtech, ask your brokers do your Due Diligence. A growth and a comeback story.
48 million shares Issues and outstanding
Pull up a 6 month chart, hope you join us.
02/10/2023
The Stem Cell Market is explosive. We are all looking to cheat time. Being as healthy as possible is a good start. Take a minute to understand Stemtech 🙏🏼🙌🏼
Stemtech a publicly traded company (STEK)
01/29/2023
Stem Cell Market growing and in our opinion, there is a huge explosion coming in this sector.
(STEK)
Jan 27, 2023 (AmericaNewsHour) -- The report titled "Global Stem Cell Treatment Market: Global Demand Analysis & Opportunity Outlook 2027" delivers...
Be the first to know and let us send you an email when Equity Alert posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
This page is a wholly owned subsidiary of Media One LLC, herein referred to as MO LLC.
Our reports/releases are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use.
PLEASE NOTE WELL: MO LLC and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.
Release of Liability: Through use of this website viewing or using you agree to hold MO LLC, its operator’s owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. MO LLC encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and MO LLC makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead MO LLC strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. MO LLC is compliant with the Can Spam Act of 2003. SCS LLC does not offer such advice or analysis, and MO LLC further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.
The Private Securities Litigation Reform Act of 1995 provides investors a ‘safe harbor’ in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”, “estimates”, “believes”, “understands”, or that by statements indicating certain actions & quote; “may”, “could”, or “might” occur. Understand there is no guarantee past performance will be indicative of future results.
